These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 15721415
1. Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study. Reesink-Peters N, Hougardy BM, van den Heuvel FA, Ten Hoor KA, Hollema H, Boezen HM, de Vries EG, de Jong S, van der Zee AG. Gynecol Oncol; 2005 Mar; 96(3):705-13. PubMed ID: 15721415 [Abstract] [Full Text] [Related]
2. Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer. Zhou JH, Chen HZ, Ye F, Lu WG, Xie X. Oncol Rep; 2006 Aug; 16(2):307-11. PubMed ID: 16820908 [Abstract] [Full Text] [Related]
3. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer. Odoux C, Albers A, Amoscato AA, Lotze MT, Wong MK. Int J Cancer; 2002 Feb 01; 97(4):458-65. PubMed ID: 11802207 [Abstract] [Full Text] [Related]
5. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N, Poulaki V, Mitsiades C, Tsokos M. Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151 [Abstract] [Full Text] [Related]
6. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Song JH, Bellail A, Tse MC, Yong VW, Hao C. J Neurosci; 2006 Mar 22; 26(12):3299-308. PubMed ID: 16554480 [Abstract] [Full Text] [Related]
10. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines. Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS. Neurosurg Focus; 2002 Sep 15; 13(3):ecp1. PubMed ID: 15844877 [Abstract] [Full Text] [Related]
11. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells. Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K, Nakazawa S. Blood; 2003 May 01; 101(9):3658-67. PubMed ID: 12506034 [Abstract] [Full Text] [Related]
12. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. Ozawa F, Friess H, Kleeff J, Xu ZW, Zimmermann A, Sheikh MS, Büchler MW. Cancer Lett; 2001 Feb 10; 163(1):71-81. PubMed ID: 11163110 [Abstract] [Full Text] [Related]
13. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Shetty S, Gladden JB, Henson ES, Hu X, Villanueva J, Haney N, Gibson SB. Apoptosis; 2002 Oct 10; 7(5):413-20. PubMed ID: 12207174 [Abstract] [Full Text] [Related]
16. Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma. Arts HJ, de Jong S, Hollema H, ten Hoor K, van der Zee AG, de Vries EG. Gynecol Oncol; 2004 Mar 10; 92(3):794-800. PubMed ID: 14984943 [Abstract] [Full Text] [Related]
17. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Immunity; 2000 Jun 10; 12(6):611-20. PubMed ID: 10894161 [Abstract] [Full Text] [Related]
18. Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks. Bertram H, Nerlich A, Omlor G, Geiger F, Zimmermann G, Fellenberg J. Mod Pathol; 2009 Jul 10; 22(7):895-905. PubMed ID: 19305384 [Abstract] [Full Text] [Related]